Requirement of Rac1 in the development of cardiac hypertrophy
- 9 May 2006
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 103 (19) , 7432-7437
- https://doi.org/10.1073/pnas.0510444103
Abstract
The development of cardiac hypertrophy is mediated, in part, by increase in NADPH oxidase activity and myocardial oxidative stress. The Rho GTPase, Rac, regulates NADPH oxidase activity through interaction with gp91phox and p67phox (in which “phox” is phagocyte oxidase). However, it is not known which Rac isoform mediates this effect in the heart. Here we show that Rac1 is critical for generating oxidative stress and producing cardiac hypertrophy in the adult heart. The Rac1 gene was temporally and specifically deleted in adult mouse cardiomyocytes (c-Rac1−/−). Compared with wild-type or Rac1 heterozygous mice, the hearts of c-Rac1−/− mice showed decreased gp91phox and p67phox interaction, NADPH oxidase activity, and myocardial oxidative stress in response to angiotensin II (400 ng/kg per day for 2 weeks) stimulation. This result correlated with decreased myocardial hypertrophy. These results indicate that Rac1 is critical for the hypertrophic response in the heart and suggest that therapies which target myocardial Rac1 may be beneficial in the treatment of cardiac hypertrophy.Keywords
This publication has 32 references indexed in Scilit:
- Decreased vascular lesion formation in mice with inducible endothelial-specific expression of protein kinase AktJournal of Clinical Investigation, 2006
- Decreased Perivascular Fibrosis but Not Cardiac Hypertrophy in ROCK1 +/− Haploinsufficient MiceCirculation, 2005
- Caveolin-1 Is Essential for Activation of Rac1 and NAD(P)H Oxidase After Angiotensin II Type 1 Receptor Stimulation in Vascular Smooth Muscle CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophyJournal of Molecular and Cellular Cardiology, 2003
- The Small GTP-binding Protein Rac1 Induces Cardiac Myocyte Hypertrophy through the Activation of Apoptosis Signal-regulating Kinase 1 and Nuclear Factor-κBPublished by Elsevier ,2003
- Statins as antioxidant therapy for preventing cardiac myocyte hypertrophyJournal of Clinical Investigation, 2001
- A requirement for the rac1 GTPase in the signal transduction pathway leading to cardiac myocyte hypertrophy.Journal of Clinical Investigation, 1998
- Disturbed interaction of p21-rac with mutated p67-phox causes chronic granulomatous disease.The Journal of Experimental Medicine, 1996
- Hypercholesterolemia increases endothelial superoxide anion production.Journal of Clinical Investigation, 1993
- Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart StudyNew England Journal of Medicine, 1990